Literature DB >> 11408017

Accumulation of macrophages in primary sclerosing cholangitis.

R G Cameron1, L M Blendis, M G Neuman.   

Abstract

OBJECTIVES: To determine what changes are occurring in patients with primary sclerosing cholangitis (PSC) by examining perisinusoidal macrophages (Kupffer cells) in liver biopsies; 2-to measure transforming growth factor beta (TGFbeta) as a marker of fibrosis in these patients. DESIGN AND METHODS: Transmission electron microscopy and immunohistochemistry of 15 PSC, 26 primary biliary cirrhosis (PBC), 30 alcoholic liver disease (ALD) and 51 with normal histology was used. Five PSC, 30 ALD and 120 normal volunteers were sampled for serum levels of TGFbeta.
RESULTS: There was a three-fold increase in relative numbers of Kupffer cells in PSC compared to PBC and to patients whose livers had normal histology. In PSC there was an accumulation of perisinusoidal macrophages, which was not associated with focal necrosis or with cholestasis. The levels of TGFbeta in PSC were 54 +/- 2 in cirrhotic versus 34 +/- 5 in non-cirrhotic patients (p < 0.005).
CONCLUSION: The persistent activation of these macrophages may lead to the chronic release of TGFbeta and contribute to chronic inflammation, fibrosis and cirrhosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11408017     DOI: 10.1016/s0009-9120(01)00215-6

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  22 in total

1.  Armed CD4+ Th1 effector cells and activated macrophages participate in bile duct injury in murine biliary atresia.

Authors:  Cara L Mack; Rebecca M Tucker; Ronald J Sokol; Brian L Kotzin
Journal:  Clin Immunol       Date:  2005-05       Impact factor: 3.969

2.  Cutting edge issues in primary sclerosing cholangitis.

Authors:  Christopher L Bowlus
Journal:  Clin Rev Allergy Immunol       Date:  2011-10       Impact factor: 8.667

3.  CFTR dysfunction predisposes to fibrotic liver disease in a murine model.

Authors:  Camilia R Martin; Munir M Zaman; Gyanprakash A Ketwaroo; Abdul Q Bhutta; Emmanuel Coronel; Yury Popov; Detlef Schuppan; Steven D Freedman
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-06-07       Impact factor: 4.052

Review 4.  Macrophages: master regulators of inflammation and fibrosis.

Authors:  Thomas A Wynn; Luke Barron
Journal:  Semin Liver Dis       Date:  2010-07-21       Impact factor: 6.115

5.  Structural examination of tryptase- and chymase-positive mast cells in livers, containing metastases from gastrointestinal cancers.

Authors:  Maya Vladova Gulubova
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

Review 6.  Mechanisms of tissue injury in autoimmune liver diseases.

Authors:  Evaggelia Liaskou; Gideon M Hirschfield; M Eric Gershwin
Journal:  Semin Immunopathol       Date:  2014-08-01       Impact factor: 9.623

7.  Transforming growth factor-beta (TGF-beta) protein levels are not elevated in the blood or bile of patients with primary sclerosing cholangitis: a pilot study.

Authors:  J K Watt; K Hawkins; M Zhang; J Lipschitz; G Sandha; Y Gong; J Uhanova; G Y Minuk
Journal:  Dig Dis Sci       Date:  2004-01       Impact factor: 3.199

8.  Glycochenodeoxycholic Acid Does Not Increase Transforming Growth Factor-Beta Expression in Bile Duct Epithelial Cells or Collagen Synthesis in Myofibroblasts.

Authors:  Anna Wang; Dorothy Yu; Yuewen Gong; Jessie Garber; Gerald Y Minuk
Journal:  J Clin Exp Hepatol       Date:  2017-05-13

9.  Senescent cholangiocytes release extracellular vesicles that alter target cell phenotype via the epidermal growth factor receptor.

Authors:  Mohammed S Al Suraih; Christy E Trussoni; Patrick L Splinter; Nicholas F LaRusso; Steven P O'Hara
Journal:  Liver Int       Date:  2020-07-07       Impact factor: 5.828

Review 10.  The immunobiology of primary sclerosing cholangitis.

Authors:  Jonathan H Aron; Christopher L Bowlus
Journal:  Semin Immunopathol       Date:  2009-05-26       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.